News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis India Limited (NVS) Gets 5-Year Marketing Rights For Anti-Cancer Drug



10/19/2005 5:10:32 PM

Novartis India Ltd. , the Indian unit of Swiss drug major Novartis AG , has received exclusive marketing rights for five years for its anti-cancer drug Glivec from the Patents and Trademarks of India.

Read at Dow Jones


comments powered by Disqus
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES